Repligen Corp (NASDAQ:RGEN)

37.63
Delayed Data
As of Apr 20
 +0.19 / +0.51%
Today’s Change
29.56
Today|||52-Week Range
46.81
+3.72%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close37.44
Today’s open37.25
Day’s range37.14 - 37.72
Volume135,243
Average volume (3 months)266,107
Market cap$1.6B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+111.76%
Earnings growth (this year)+1.09%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+35.10%
P/E ratio52.3
Price/Sales10.06
Price/Book2.75

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.30-1.49%
ARRYArray Biopharma Inc-0.35-2.42%
LXRXLexicon Pharmaceutic...+0.05+0.60%
CBMCambrex Corp-0.05-0.09%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.18
Annual revenue (last year)$141.2M
Annual profit (last year)$28.4M
Net profit margin20.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts